ISOPP Contributes to Global Health Policy

Posted on:

ISOPP Contributes to Global Health Policy              

We are proud to share that several ISOPP members from the ISOPP Advocacy committee, chaired by Esin Kandemir, played a pivotal role in shaping the 25th WHO Expert Committee on the Selection and Use of Essential Medicines report.

Their expertise in oncology pharmacy helped guide decisions that impact access to essential cancer treatments worldwide. Theis work highlights the value of oncology pharmacy voices in global essential medicines policy.

Link to the WHO report 

Related News

ISOPP News

Your bispecific antibody questions, answered by our expert pharmacists. HOPA is proud to introduce the new Pharmacy Peer Network, which provides timely, one-on-one access to subject matter experts who can help individuals navigate questions and challenges related to bispecific therapies with confidence.

ISOPP News

Understanding Targeted Therapies and Immunotherapies for Cancer ISOPP's Understanding Targeted Therapies and Immunotherapies for Cancer (UTIC) course - developed in collaboration with the British Oncology Pharmacy Association - is currently available on our e-learning platform.

ISOPP News

New 2026-2027 Secretariat (Incoming) Congratulations!